Trial intelligence / Profile preview

Thyroid Function in Pediatric Subjects Exposed to ISOVUE

NCT03779906Phase 4Terminated

Sponsor
Bracco Diagnostics Inc.
Start
Mar 2019
Primary completion
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of iopamidol, sponsored by Bracco Diagnostics Inc.. Started Mar 2019; status: terminated.

02

Drugs

iopamidol

Beyond the preview

Go deeper on NCT03779906.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03779906.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call